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Abstract
Human adipose tissue is a great source of adult mesenchymal stem cells (MSCs) which are recognized from their ability to self-renew and dif-
ferentiation into multiple lineages. MSCs have promised a vast therapeutic potential in treatment many diseases including tissue injury and
immune disorders. However, their regenerative potential profoundly depends on patients’ age. Age-related deterioration of MSC is associated
with cellular senescence mainly caused by increased DNA methylation status, accumulation of oxidative stress factors and mitochondria dys-
function. We found that DNA methyltransferase (DNMT) inhibitor i.e. 5-Azacytidine (5-AZA) reversed the aged phenotype of MSCs. Proliferation
rate of cells cultured with 5-AZA was increased while the accumulation of oxidative stress factors and DNA methylation status were decreased.
Simultaneously the mRNA levels of TET proteins involved in demethylation process were elevated in those cells. Moreover, cells treated with
5-AZA displayed reduced reactive oxygen species (ROS) accumulation, ameliorated superoxide dismutase activity and increased BCL-2/BAX
ratio in comparison to control group. Our results indicates that, treating MSCs with 5-AZA can be justified therapeutic intervention, that can
slow-down and even reverse aged- related degenerative changes in those cells.
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Introduction
The populations of many regions, especially in developed countries,
are rapidly growing older. [1]. That fact become a real challenge for
national healthcare systems, economy and medicine. Although the
portion of the elderly that faces severe disability is decreasing, they
still share a great susceptibility to various chronic conditions and dis-
abilities like osteoporosis and osteoarthritis. Thus, elderly patients,
become a group that require an effective and rapid therapeutic treat-
ment. Recently, a lot of attention has been paid to regenerative medi-
cine- a novel therapeutic strategy that include preparation of
functionalized biomaterials, development of sufficient pharmaceutical
agents based on cellular therapy [2, 3].
Regenerative medicine and/or tissue engineering has a great thera-
peutic potential and might be an effective strategy for treating elderly
patients. Currently, there are 344 registered clinical trials in different
phases aimed at evaluating the potential of mesenchymal stem cells
(MSC) based therapy worldwide [4, 5]. Due to their accessibility and
convenient expansion protocols, MSC have been recognized as promis-
ing candidates for cellular therapy. The potential of MSC therapy
involves their unique characteristics: self-renewing and multilineage
potential to differentiate into cell types of mesodermal origin. Moreover,
MSC can migrate to the inflammation site and exert potent immuno-
suppressive and anti-inflammatory effects through interactions
between lymphocytes. Because of their characteristics, MSC are being
explored in trials of various conditions, including tissue injury and
immune disorders [6–9]. What is worth noting, many independent clin-
ical trials in regenerative medicine, already showed the effectiveness of
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MSCs engraftment in regeneration of musculoskeletal system [10] neu-
ronal [11, 12] and cardiac tissue [13, 14]. However, as recently showed
MSCs regenerative potential decreases with patients age. The impair-
ment of MSCs properties, including decreased proliferation rate,
increased apoptosis and senescence, might lead to unsatisfactory clini-
cal results [15, 16]. Hence, the analysis of MSCs molecular condition
on various levels, before their application, seems to be highly reason-
able. Especially, while taking into consideration the ageing phenotypes
of those cells caused by different intracellular factors and also by the
ageing of stem cells niche itself.
Several studies, including ours, showed that MSCs isolated from
adipose tissue (hASCs) of elderly patient are characterized by the ele-
vated oxidative stress levels, and therefore suffer from increased
senescence, impairment of cellular viability and activity [15, 17, 18].
The both: oxidative stress and epigenetic modifications of the genome
are recognized as crucial factors initiating MSCs ageing and senes-
cence, that in consequence leads to the impairment of their regenera-
tive potential [19, 20]. Increased accumulation of reactive oxygen
species (ROS) and nitric oxide, simultaneously with decreased anti-
oxidative protection coming from superoxide dismutase (SOD) activ-
ity leads to the state of permanent growth arrest or apoptosis [21]. In
this case the initiation of apoptosis is carried out by up-regulation of
p21, p53 (tumour suppressor), BAX expression, cytochrome C relo-
cation, chromatin condensation and remodelling [22, 23]. Moreover,
changes in epigenetic status of MSCs including DNA and histone
methylation can affect the MSCs viability and proliferative activity:
both crucial in the context of cellular therapies [24]. Efforts have been
made to applied histone deacetylase inhibitors (HDAC) as an anti-age-
ing factor in MSCs culture. Even if HDAC has showed to improve
osteogenic differentiation process of those cells, they simultaneously
slowed down the viability through DNA damage and cell-cycle inhibi-
tion [25, 26]. It also has been proved, that DNA demethylation can be
induced by the application of DNA methyltransferase (DNMT) inhibi-
tors i.e. 5-Azacitidine (5-AZA) [27]. That agent has been demon-
strated as an effective factor that inhibits cancer cells viability, and
thus was proposed as a therapeutic agent for treating an acute myel-
ogenous leukaemia [28, 29]. It was also observed that 5-AZA is easily
incorporated into DNA and inhibits methylation pattern of specific
gene regions, simultaneously with activation of associated genes
[30]. Epigenetic changes induced by 5-AZA in hepatocyte-like cells
lead to significantly improved metabolic and enzymatic activities com-
pared to non-treated cells [31]. These findings prompted the other
research groups to test if 5-AZA, because of their demethylation abil-
ity, might affect the MSCs viability and have found it’s beneficial effect
in the course of osteogenic differentiation process. Just recently, the
explanation of DNA demethylation mechanism, however in embryonic
stem cells (ESC) has been proposed. DNA-demethylation was
observed by induction of TET gene expression, that initiate the con-
version of nuclear 5-methylcyt-osine (5 mC) to 5-hydroxymethylcyto-
sine (5 hmC). These in consequence leads to improvement of the
self-renewal ability of ESC and maintain their pluripotent status [32].
Although MSCs for cell therapy have been shown to be safe and
effective, there are still challenges that need to be tackled before their
wide application in the clinical practice. Especially the impaired prolifer-
ative activity caused by senescence and decreased ‘stemness’ status of
those cells needs to be overcome. One of the solutions is treating
MSCs in vitro with different agents that may lead to their rejuvenation
and finally to effective and successful therapy, especially when using
cells from elderly donors which suffer from age-related deterioration.
This study investigated the effects of 5-Azacitidine on the viability
and proliferative activity of ASCs of healthy, however elderly donors.
Moreover, we analysed correlation between ROS/nitric oxide versus
SOD activity, hASCs growth kinetics, apoptotic versus anti-apoptotic
genes expression and mitochondrial morphological imperfections.
Finally, bearing in mind the fact, that 5-Azacitidine was reported as a
demethylation agents in embryonic stem cells, that maintain their
pluripotency, we tested the expression level of TET2/3 genes in rela-
tion to 5-methylocysteine conversion for 5-hydroxymethylcysteine.
Materials and methods
All reagents used in this experiment were purchased from Sigma-
Aldrich (Poznan, Poland), unless indicated otherwise.
All experimental procedures were approved by the II Local Ethics
Committee of Environmental and Life Sciences University (Chel-
monskiego 38C, 51-630 Wroclaw, Poland; decision No. 84/2012). An
informed, written consent for using the samples for research purposes
was obtained from all patients prior to surgery. The study has been per-
formed in accordance with the ethical standards laid down in the 1964
Declaration of Helsinki and its later amendments.
Isolation of adipose-derived mesenchymal stem
cells (ASCs)
Human subcutaneous adipose tissue was collected from both male and
female subjects; age range 52–78 (median age equalled 67). After surgical
harvesting adipose tissue samples were placed in Hank’s Balanced Salt
Solution (HBSS) and processed under the same, sterile conditions. Isolation
of ASCs was performed in accordance to a previously described protocol
[33]. Briefly, tissue fragments were washed extensively with HBSS supple-
mented with 1% antibiotic-antimycotic solution (penicillin/streptomycin/
amphotericin B) and minced. The extracellular matrix was digested with
collagenase type I (1 mg/ml) for 40 min. at 37°C and 5% CO2. Next, tissue
homogenates were centrifuged for 10 min. at 1200 9 g. The supernatants
were discarded and the pellets of stromal vascular fraction (SVF) containing
ASCs were washed with HBSS and centrifuged again for 4 min. at
300 9 g. The supernatant was discarded and the pellet was re-suspended
in the culture medium. The cell suspension was then transferred to a culture
flask. Primary culture of ASCs’ was designated as ‘passage 0’. To prepare
cells for experiment, they were passaged three times.
Flow cytometer analysis
Human ASCs were recognized by immunophenotyping using fluo-
rochrome conjugated monoclonal antibodies specific for: CD29, CD34,
CD45, CD90, CD73b and CD44. isotype-matched antibodies were used as
controls. Due to immunophenotyping ASCs were detached using TrypLETM
Express solution, washed with HBSS contained 2% FBS and re-suspended
at total of 5*105 cells/ml. Cell suspension was incubated at 4°C for
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20 min. with the specific antibodies pre-conjugated with allophycocyanin
(APC), peridinin chlorphyllprotein (PerCP), fluorescein isothiocyanate
(FITC) or phycoerythrin (PE). At least ten thousand stained cells were
acquired and analysed by Becton Dickinson FACS Calibur flow cytometer.
The samples were analysed using CellQuest Pro software (Becton Dickin-
son, Franklin Lanes, New Jersey, USA).
Multipotency assay of ASCs
Osteogenic, chondrogenic and adipogenic differentiation of cells were
induced using commercial kits (STEMPRO Osteogenesis Differentiation
Kit and STEMPRO Adipogenesis Differentiation Kit, both Life Technolo-
gies, Waltham, Massachusetts, USA) in accordance to manufacturers’ pro-
tocols. In order to perform the test, the cells were seeded in a 24-well plate
at the initial density of 2 9 104 and the media were changed every 2 days.
Experiments were carried out simultaneously, each in triplicate. Stimulation
of osteo- and chondrogenesis lasted 21 days, while stimulation towards
adipogenic lineage lasted for 14 days. Cultures expanded in standard
growth medium were used as a control to allow for establishing differentia-
tion effectiveness. Multi-lineage differentiation was confirmed at 2 weeks
post-induction by cells staining. To evaluate the results of differentiation
process cells were fixed with 4% ice-cold paraformaldehyde (PFA) and
specific stainings were performed. Extracellular mineralized matrix was
visualized with Alizarin Red dye, while the formation of proteoglycans was
confirmed by Safranin O. Intracellular lipid droplets were stained red with
Oil Red O. Cells were observed under an inverted microscope (AxioObser-
verA1, Zeiss (Oberkochen, Germany)) and photographs were acquired
using Cannon PowerShot digital camera.
Cell culture
The cells were cultured in DMEM with the F-12 Ham’s nutrient supple-
mented with 10% of foetal bovine serum (FBS) and 1% P/S/A solution.
During the experiment, the cells were cultured under aseptic and con-
stant conditions in an incubator (37°C, 5% CO2 and 95% humidity). The
media were changed every 2 days and the cells were passaged using
trypsin solution (TrypLETM Express; Life Technologies, Warsaw, Poland)
according to manufacturers’ instructions after reaching 80% confluence.
Pre-treatment of ASCs with 5-AZA
Prior experiment ASCs were seeded onto 24-well plates at the density
of 20 9 103 per well. After cell attachment culture medium was
replaced with medium containing 5-AZA (1 lM). After total pre-treat-
ment (48 h) with 5-AZA, cells were maintained in standard culture med-
ium again. Cells cultured in standard medium (DMEM, 10% of FBS, 1%
P/S/A) without addition of 5-AZA served as a control group. Non-treated
cells served as a control for comparison with the test culture. All exper-
iments were performed after seventh day of experiment.
Cell viability, population doubling time and
colony forming unit-fibroblasts (CFU-fs) assay
Cell proliferation rate was evaluated using 10% resazurin-based dye-TOX-8
(Sigma-Aldrich) following manufacturer’s protocols. To perform the test,
culture media were removed and replaced with culture medium containing
10% of the dye. The cells were then incubated with the dye in the CO2
incubator, 37°C for 2 hrs. Supernatants were collected and transferred to
96-well plate to perform the spectrophotometric assay (BMG Labtech,
Ortenberg, Germany). The absorbance of the supernatants was measured
at a wavelength of 600 nm for resazurin, and 690 nm reference wave-
length. Each measurement included a blank sample, containing medium
without cells. The number of cells was estimated on the basis of standard
curve, generated during the experiment. To prepare the curve, cells were
seeded at the density of 20 9 103, 40 9 103, 80 9 103 per well and dye
absorbance was measured in relation to certain cells number. Linear trend-
line equation allowed estimating cells number throughout the experiment.
Population doubling time (PDT) was assessed with the support of a pop-
ulation doubling time on-line calculator (http://www.doubling-time.com/
compute.php) using formula presented below. Initial concentration equalled
2 9 104 cells, (initial seeding density) while final concentration equalled
the number of cells in culture on the seventh day of the experiment.
PDT ¼ duration  logð2Þ
logðFinal ConcentrationÞ  logðInitial ConcentationÞ
To evaluate the ability of cells to form colonies, ASCs were seeded in
six-well plates at a density of 100 cells per well and inoculated into a
culture medium. The medium was changed every 2 days and cultures
were maintained for 7 days. After fixation in 4% ice-cold paraformalde-
hyde, cells were stained with pararosaniline solution and colonies of
more than 50 cells were counted and documented by a Power Shot
Camera. The efficiency of colony forming was calculated using the
formula presented below, as described elsewhere [34].
CFU-fs½% ¼ the number of colonies
initial cell number
 100%
Measurement of DNA synthesis: BrdU assay
DNA synthesis was assessed by measuring the incorporation of
5-bromo-2-deoxyuridine (BrdU) into cellular DNA. The test was per-
formed after 48, 96 and 168 hrs of culture. The assay was performed
with BrdU Cell Proliferation ELISA Kit (Abcam, Milton, Cambridge CB4
0FL, United Kingdom) in accordance to manufacturer’s instruction.
Briefly, cells were incubated with BrdU overnight at 37°C. Next, cells
were fixed and DNA was denaturated. Incorporation of BrdU was deter-
mined by incubation with anti-BrdU monoclonal antibody. Goat anti-
mouse IgG conjugated with horseradish peroxidase (HRP), was used as
a secondary antibody. Colour reaction was developed using 3,3,5,5-tet-
ramethylbenzidine (TMB). Signal intensity was measured with a spec-
trophotometer plate reader (BMG Labtech, Ortenberg, Germany), at a
wavelength of 450/550 nm.
Examination of ASCs morphology and
ultrastructure
Cell morphology was assessed using an inverted epifluorescent micro-
scope (Zeiss, Axio Observer A.1). The preparation of cells for fluores-
cent microscopy included following stages (i) washing three times with
HBSS, (ii) fixation in 4% PFA, (iii) washing with HBSS, (iv) permeabi-
lization by 0.2% Tween 20 in HBSS for 15 min. at room temperature,
(v) washing with HBSS. Next, actin filaments were stained using atto-
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565-labeled phalloidin at dilution 1:800 with HBSS for 40 min. in the
dark at room temperature and cells’ nuclei were counterstained with
diamidino-2-phenylindole (DAPI; 1:1000) for 5 min. In addition, percent-
age of enlarged cells was calculated based on the representative images
(cells were qualified as ‘enlarged’ when cell diameter was greater than
>280 lm) as spread -out, flattened morphology and increased nuclei
size, typical features associated with ASC senescence.
Detailed characteristics of ASCs morphology were evaluated using
scanning electron microscope (Zeiss EVO LS15). After fixation in 4%
PFA cells were washed with HBSS three times and dehydrated in a
graded ethanol series (from 50% to 100%). Air-dried samples were
then sputtered with gold (Scancoat Six, Crawley, United Kingdom),
placed in a microscope chamber and observed using a SE1 detector, at
10 kV of filament’s tension. Using SEM data, we also evaluated mean
cell nuclei diameter.
For transmission electron microscopy (TEM), cells were fixed in
2.5% glutaraldehyde at 4°C. After fixation step cells were: (i) cen-
trifuged at 2000 9 g for 10 min. and rinsed with PBS for 30 min., (ii)
centrifuged again, parameters as above, (iii) incubated with 1% osmium
tetroxide in HBSS for 2 hrs, (iv) washed with HBSS, (v) centrifuged as
described above, (vi) dehydrated in graded acetone series (30–100%),
(vii) embedded using Agar Low Viscosity Resin Kit (Agar Scientific Ltd,
Essex, UK). Ultrathin sections (80 nm) were collected on copper grinds.
Uranyl acetate and lead citrate were used for contrasting for 30 and
15 min. respectively. The observations were carried out using Auriga60
Zeiss STEM (Oberkochen, Germany), at 20 kV filament tension.
The diameter of cell nuclei observed under SEM was calculated
based on the representative images. The percentage of heterochromatin
in nuclei observed under TEM was calculated by ImageJ software (Ras-
band, W.S., Image J, U. S. National Institutes of Health, Bethesda,
Maryland, USA, http://imagej.nih.gov/ij/, 1997-2016.).
Visualization of tubulin, Golgi apparatus and
endoplasmic reticulum (ER)
To visualize cells’ organelles commercially available kits were applied.
Tubulin was stained with a red fluorescent protein, using CellLight
Tubulin-RFP, BacMam 2.0 (Life Technologies), Golgi apparatus was
labelled with a green fluorescent protein, using CellLight Golgi-GFP,
BacMam 2.0 (Life Technologies), and endoplasmic reticulum was
stained with a red fluorescent protein using CellFight ER-RFP, BacMam
2.0 (Life Technologies) following manufacturers’ instructions. Briefly,
cells were incubated overnight in the CO2 incubator, 37°C. Next cells
were washed three times with HBSS, fixed in 4% PFA for 40 min. and
washed again. Cells nuclei were counterstained with DAPI.
Senescence, oxidative stress factors, ATP and
DNA methylation analysis after 7 days culture
To visualize senescence-associated b-galactosidase, we performed
staining using Senescence Cells Histochemical Staining Kit (Sigma-
Aldrich) following the manufacturer’s protocol. Amount of viable and
dead cells was evaluated with Cellstain Double Staining Kit (Sigma-
Aldrich). Viable cells were stained with Calcein-AM and emitted green
fluorescence, whereas dead cells’ nuclei were stained orange with Pro-
pidium Iodide. The percentage of dead cells was calculated. The cells
were observed using epifluorescence microscopy and all procedures
were conducted in accordance with the manufacturer’s instructions. The
amount of adenosine triphosphate (ATP) produced by investigated cells
was performed with ATP assay kit (Abcam). All procedures were per-
formed according to manufacturer’s protocols.
To evaluate stress levels, the cells were cultured in medium without phe-
nol red for 7 days and the tests were performed on the second and seventh
day. Nitric oxide concentration was assessed with the Griess Reagent Kit
(Life Technologies), SOD by SOD Assay Kit and the level of ROS was esti-
mated with a H2DCF-DA (Life Technologies) solution. All procedures were
performed in duplicate in accordance to the manufacturer’s protocols. In
addition, we performed fluorescence staining for ROS using Total ROS
detection kit for microscopy and flow cytometry (Enzo Life Sciences, New
York, USA). To confirm whether ROS mainly come from mitochondria, we
counterstained them with Mito Red dye (dilution 1:1000). All procedures
were performed following manufacturers’ instructions.
Moreover, we established DNA methylation status using DNA Methyla-
tion EIA Kit (Cayman Chemical, Ann Arbor, Michigan, USA) for quantita-
tive data. To perform the assay DNA was purified from cells using
Genomic DNA Purification kit (Thermo Fisher Scientific (Waltham, Mas-
sachusetts, Stany Zjednoczone)). Next, DNA was digested using nuclease
S1 (Thermo Fisher Scientific) following incubation with alkaline phos-
phatase at 37°C for 30 min. Samples were then boiled for 10 min. and
placed on ice until use. To perform the test 400 ng of DNA was used. All
procedures were conducted following manufacturers’ instructions.
Immunofluorescence stainings
To perform the analysis, cells were fixed in 4% PFA for 40 min. and
washed three times with HBSS. For permeabilization, cells were incu-
bated with 0.5% Triton X-100 for 20 min. at room temperature. Follow-
ing HBSS wash, unspecific binding sites were blocked with blocking
buffer (10% Goat Serum, 0.2% Tween-20 in HBSS) for 45 min. Then,
the cells were incubated with primary antibodies against Ki67 and Cas-
pase-3 (both from Abcam) diluted 1:200 in HBSS containing 1% Goat
Serum and 0.2% Tween-20. After rinsing with HBSS, cells were incu-
bated for 1 hr with mouse anti-rabbit secondary antibodies conjugated
with atto-594 and atto-488 (dilution 1:200), avoiding direct light. Nuclei
were counterstained by incubation with DAPI for 5 min.
To visualize 5-methylocytosine (5-MC) and 5-hMC cells were: (i) fixed
with 4% PFA for 40 min., (ii) permeabilized in 0.5% Triton X-100 in
HBSS, (iii) incubated with 4N HCl for 15 min., (iv) incubated with block-
ing buffer (10% Goat Serum, 0.2% Tween-20 in HBSS) for 45 min. Next,
cells were incubated with primary antibodies diluted 1:200 in HBSS con-
taining 1% Goat Serum and 0.2% Tween-20 overnight (anti-5-methylocy-
tosine, ab73938, Abcam; anti-5-hydroxymethylocytosine,ab106918,
Abcam). After washing three times with HBSS, cells were incubated with
secondary antibodies conjugated with atto-488 for 1 hr (1:200, goat anti-
rat, ab150157, Abcam; goat antimouse, ab150113, Abcam).
Analysis of gene expression: real-time reverse
transcription polymerase chain reaction (qRT-PCR)
On the seventh day of the experiment, cells were homogenized using 1 ml
TRI Reagent. Procedure of homogenization was performed directly in the
culture dish. Total RNA was isolated using the phenol–chloroform method
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as previously described by Chomczynski & Sacchi [35]. Obtained samples
were diluted in DEPC-treated water. Both, quality and quantity of isolated
total RNA were determined using nano-spectrometer (WPA Biowave II,
Hercules, California, USA). Genomic DNA digestion and cDNA synthesis
were performed with PrimeScript kit (Takara, Clontech, Kusatsu, Shiga,
Japan). For each reaction, 150 ng of total RNA was used. Both processes
were performed in accordance with the manufacturers’ instructions using
a T100 Thermal Cycler (Bio-Rad, Hercules, California, USA).
The qRT-PCR reactions were performed with a CFX ConnectTM Real-
Time PCR Detection System (BioRad). Reaction mixture contained 2 ll
of cDNA in a total volume of 20 ll using SensiFast SYBR & Fluorescein
Kit (Bioline, Cincinnati, Ohio, USA). The concentration of primers in
each reaction equalled to 500 nM; primer sequences used in individual
reactions are listed in Table 1. Relative gene expression analysis (Qn)
was calculated in relation to the GAPDH housekeeping gene.
Moreover, we evaluated the ratio between BCL-2 and BAX expression
in each group by dividing Qn of BCL-2 by Qn of BAX.
Statistical analysis
Results are shown as growth curves or box plots of at least three inde-
pendent experiments, measured as triplicates or more. Statistical signifi-
cance was determined using the unpaired t-test or one-way ANOVA with
Tukey’s post hoc test (Prism5.04, GraphPad Software, CA, USA).
P < 0.05 was considered statistically significant.
Results
5-AZA treatment maintain the expression of ASC
specific surface antigens and ASC multipotency
To confirm multipotent and mesenchymal character of isolated cells
flow cytometry and multipotency assay were performed. Flow cytome-
ter analysis revealed that ASCs were positive for mesenchymal markers
specific for multipotent stromal stem cells, e.g. CD44, CD73 and
CD105. On the contrary, ASCs showed a negative reaction with the
CD34 and CD45 hematopoietic markers (Fig. 1A, B). The multipotency
of isolated cells was confirmed by the positive results of osteo-, chon-
dro- and adipogenic differentiation. Cells cultured in osteogenic med-
ium formed extracellular mineralized matrix stained with Alizarin Red.
Cells cultured under chondrogenic conditions formed proteoglycan rich
matrix stained with Safranin O. In adipogenic cultures, cells formed
intracellular lipid vacuoles stained red with Oil Red O (Fig. 1C).
Table 1 Sequences of primers used in qPCR.
Gene Primer Sequence 50–30 Amplicon length (bp) Accesion no.
BAX F: ACCAAGAAGCTGAGCGAGTGTC 365 XM_011527191.1
R: ACAAAGATGGTCACGGTCTGCC
BCL-2 F: ATCGCCCTGTGGATGACTGAG 129 NM_000633.2
R: CAGCCAGGAGAAATCAAACAGAGG
TET2 F: GAGACGCTGAGGAAATACGG 258 XM_011532044.1
R: TGGTGCCATAAGAGTGGACA
TET3 F: CAGAACGCTGTGATCGTCAT 263 XM_011532690.1
R: AACTTGCGAGGTGTCTTGCT
p21 F: GGCAGACCAGCATGACAGATTTC 72 NM_001291549
R: CGGATTAGGGCTTCCTCTTGG
p53 F: AGATAGCGATGGTCTGGC 381 NM_001126118.1
R: TTGGGCAGTGCTCGCTTAGT
Lin28 F: CCGAACCCCATGCGCACGTT 137 NM_024674.5
R: TTTGCAGGTGGCTGCGCCAAG
GAPDH F: CATGGCCTTCCGTGTTCCTA 286 NM_017008.4
R: CACCACCCTGTTGCTGTAGC
Sequences, amplicon length and accession numbers of the primer sets; BAX- BCL2-Associated X Protein; BCL-2- B-cell lymphoma 2; TET2- tet
methylcytosine dioxygenase 2; TET3- tet methylcytosine dioxygenase 3; p21 – cyclin-dependent kinase inhibitor 1A; p53 – tumor suppressor
p53; Lin28- lin-28 homolog A, GAPDH – glyceraldehyde 3-phosphate dehydrogenase
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Treatment with 5-AZA increased ASCs
proliferations as seen by increase Ki67 and
decrease population doubling time
The proliferative activity of ASCs cultured both, in control and
1 lM of 5-AZA supplemented medium was evaluated after 24, 48,
96 and 168 hrs of culture. Cell activity in control culture declined
after 24 hrs and began to increase after 48 hr till the last day of
the experiment. Proliferation of cells cultured with 5-AZA was char-
acterized by exponential cell growth during the whole experiment
(Fig. 2A). Those cells displayed significant increase in number in
comparison to control group on each investigated day. The greatest
Fig. 1 Flow cytometry and multipotency analysis of isolated hASCs. Phenotype of hASCs was determined with flow cytometry. Isolated cells
were strongly positive for CD 44, CD73, CD105 surface antigens. In contrast cells lacked the expression of hematopoietic markers CD45 and CD 34
(A,B). Representative images from tri-lineage assay (C). Osteogenesis was confirmed with Alizarin Red staining for extracellular matrix mineralization
while proteoglycans formed during chondrogenesis were stained with Safranin O. Formation of intracellular lipid-reached vacuoles as typical charac-
teristic of adipogenic process was visualized with Oil Red O. Magnification 9100, scale bars 250 lm.
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Fig. 2 Influence of 5-AZA treatment on hASCs growth kinetics and clonogenic potential. Mean cells number was assessed using Alamar Blue test
(A). Cells cultured with culture medium supplemented with 5-AZA displayed higher proliferation rate in comparison to control group during the
whole experimental period. The greatest significances were observed after 48 and 96 hrs of culture (P < 0.001). In respect to growth curve data,
mean population doubling time was calculated (PDT) (B). To perform the CFU assay cells were seeded at the initial density of 100 cells/per well
onto six-well culture plate. After 7 days of cultures colonies were scored and CFU-F efficiency was calculated using mentioned equation. Obtained
results showed greatest potential to form colonies in hASCs treated with 5-AZA (P < 0.01). Visualization of CFU-F colonies stained with Pararosani-
line (C). CFU-F assay showing percentage of colonies consisting of more than 50 cells (D). Proliferative cells were visualized using immunofluores-
cence stainings for Ki67 antigen (green), which is located in cell’s nucleus during all active phases of the cell cycle (despite Go phase). Cells nuclei
were counterstained with DAPI (blue) (E). Representative images of Ki67 were used for quantification of Ki-67 positive cells (F). The obtained data
points to increased proliferation of hASCs after treatment with 5-AZA (P < 0.01) in comparison to control group. In addition, the relative activity of
cells that were replicating their DNA was assessed with BrdU incorporation assay after 48, 96 and 168 hrs of culture (G). After 168 hrs of culture
we noted significantly increased DNA synthesis (P < 0.01) in cells treated with 5-AZA. Magnification 9100, scale bars 250 lm; *P < 0.05,
**P < 0.01.
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differences in cell number were observed after 48 and 96 hrs of
culture (P < 0.001), while on day 7th difference was less
(P < 0.01), probably because growth inhibition caused by high
confluence on plate wells.
Moreover, time required to double the population was significantly
reduced in ASCs cultured with 5-AZA in comparison to control culture
(P < 0.05) (Fig. 2B).
The ability of cells to form colonies originated from one cell, was
established with clonogenic fibroblast precursor (CFU-F) assay. The
greatest number of colonies consisted of more than 50 cells was
observed in ASCs cultured with 5-AZA (P < 0.01). These data were
showed qualitatively on the pictures (Fig. 2C) and quantitatively on
the graph (Fig. 2D).
Proliferative activity of ASCs was also established with
immunofluorescence staining for intranuclear Ki67 (Fig. 2E). Data
were presented qualitatively on pictures and quantitatively on graphs.
Percentage of the cells with positive Ki67 was calculated from 10 dif-
ferent pictures. Expression of Ki67 was significantly increased in 5-
AZA (<0.01) treated cells, representing an increased proliferative
capacity in comparison to control culture (Fig. 2F).
The curve established for BrdU incorporation after 48, 96 and
168 hrs of culture displayed exponential character in both cultures. In
5-AZA treated cells, we observed increased BrdU accumulation, but
only on the seventh day, it was significantly higher in comparison to
the control culture (P < 0.01) (Fig. 2G).
The morphology and ultrastructure of ASCs
treated with 5-AZA supplemented culture
medium
The morphological and ultrastructural characteristics of cells cul-
tured with 5-AZA was observed on seventh day of culture and com-
pared to control culture. Analysis of cells using epi-fluorescence
microscopy revealed the characteristic features of ASCs morphology
including elongated fibroblast-like shape. In control culture, we
observed small percentage of cells exhibited more flat, expended
morphology with enlarged nucleus (indicated with white arrows on
Fig. 3A I, II, V, VI). Interestingly in 5-AZA, cultured cells displayed
more spindle-shaped, elongated morphology with no signs of apop-
tosis (no apoptotic bodies were observed). Moreover, cells treated
with 5-AZA were more concentrated, closely adhere to each other
forming aggregates and multilayer after 168 hrs of culture. Analysis
of cellular junctions formation showed that addition of 5-AZA
increased number of cytoskeleton projections, e.g. lamelli- and fil-
ipodia. In comparison, control group displayed the smallest-scale
cytonemes web connecting neighbouring cells. The number of
plasma-derived particles (microvesicles, MVs) was increased in 5-
AZA cells suggesting increased metabolic activity of those cells
(indicated with red arrows and proper abbreviations on Fig. 3A III,
IV, VII, VIII). Moreover, mean nuclei diameter was decreased in 5-
AZA cultures (Fig. 3B). Moreover, we observed that 5-AZA treat-
ment reduced the amount of enlarged cells in culture (Fig. 3C).
Staining for organelles observed under fluorescence microscope,
revealed more intense fluorescence signal for Tubulin in experimen-
tal group, which may partially explain higher proliferative activity of
those cells. Similar, most intense endoplasmic reticulum (ER) signal
was also observed in this group. Interestingly, abundance of Golgi
Apparatus signal intensity was comparable in both investigated
groups (Fig. 4A). In addition, we estimated production of MVs
using TEM. The most robust production of those membrane-parti-
cles was observed on the edge of ASCs treated with 5-AZA
(Fig. 4B).
Treatment of ASC with 5-AZA decreases
apoptosis and senescence
To determine whether treatment with 5-AZA can reduced apoptosis
and senescence levels in ASCs we evaluated percentage of dead cells
and stained cells for b-galactosidase and caspase-3 activity. Analysis
of typical signs of cell death performed on seventh day of the experi-
ment, using fluorescence and light microscopy. Live cells were
stained green with Calcein AM, whereas dead cells were stained
orange/red with Propidium Iodide (Fig. 5A). Obtained results showed
that the percentage of dead cells was decreased in 5-AZA treated cells
(P < 0.01) (Fig. 5B). Senescence associated accumulation of b-
galactosidase (b-gal) was stained blue on histology samples
(Fig. 5A). Number of positive stained cells was decreased in 5-AZA in
comparison to control group. In addition, using computer software,
we estimated percentage of stained area to provide quantitative data
(Fig. 5C). Those results showed significantly reduced (P < 0.05)
accumulation of b-gal in 5-AZA cultures. In turn, the expression of
caspase-3 staining in control group was higher when compared to
ASCs cultured with 5-AZA.
5-AZA supplementation decreases oxidative
stress in ASC
To determine whether 5-AZA treatment can influence the level of
oxidative stress factors, we evaluated the levels of ROS, nitric oxide
and SOD after 48 and 168 hrs of culture. In addition, we imaged mito-
chondria using TEM. After fluorescence staining for ROS, we
observed that ROS levels were decreased in 5-AZA culture. When
comparing ROS images with Mito Red staining, it is apparent that the
most ROS is derived from mitochondria (Fig. 6A). Reduced ROS
levels in experimental group suggest that 5-AZA improved mitochon-
drial function in ASCs. To determine whether treating cells with 5-AZA
can affect mitochondria structure, we carried out TEM analysis. Some
of mitochondria from control group displayed structure abnormalities
including disarrayed cristae, membrane rapture and formation of vac-
uoles (indicated with arrows on Fig. 6A IV, VIII). On the contrary,
mitochondria from cells treated with 5-AZA presented typical bean-
shape structure with numerous cristae. Evaluated with spectropho-
tometer ROS levels, confirmed the staining results. After 48 hrs of
culture ROS levels was comparable in both groups, while on seventh
day of culture, it decreased in 5-AZA treated ASCs (Fig. 6B). Nitric
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Fig. 3 The effect of 5-AZA treatment on hASCs morphology. Morphology of hASCs was evaluated after 48 and 168 hrs of the experiment using
immunofluorescence and SEM imaging (A). Actin cytoskeleton was stained with Atto-594 Phalloidin, whereas nuclei were counterstained with DAPI.
After 48 of culture in control group, we observed small fraction of cells presenting spread-out, flattened morphology and increased nuclei size, a
typical features associated with ASCs senescence (pointed with white arrows on picture I). In contrast, cells cultured with 5-AZA presented typical
elongated, spindle-shaped morphology. Interestingly, in this culture, small number of cells presented very small, round-like morphology (indicated
with arrows on picture V). After 168 hrs of culture cells reached high confluence in both groups, although after 5-AZA treatment cells formed dense,
multilayered aggregates and closely adhere to each other. Using SEM, we also evaluated production of MVs (III, VII). The production of MVs was
more robust in 5-AZA treated cells as we observed MVs not only on the edge of cell body but also around nucleus (VII). Those cells also developed
a long structures known as filopodia and lamellipodia, which connected adjacent cells (VIII). To investigate whether 5-AZA treatment influenced cells
nuclei morphology, we evaluated mean nuclei diameter using SEM (B). Interestingly, we observed decreased nuclei diameter in 5-AZA treated cells
(P < 0.05). In addition, based on obtained photographs, percentage of enlarged cells was calculated (C). Magnification: immunofluorescece 9100,
scale bars 250 lm; SEM III, VII 92000, scale bars 30 lm; IV, VIII 95000, scale bars: 10 lm. *P < 0.05. Abbreviations: MVs: membrane-derived
microvesicles; fp- filopodia; lp-lamellipodia.
Fig. 4 Assessment of hASCs organelles and microvesicles (MVs) production Cellular composition of hASCs (A), observed under epi-fluorescent
microscope. Morphological features are indicated with the following abbreviations: n: nucleus; t: tubulin; er: endoplasmic reticulum; g: Golgi appara-
tus. In control group, we observed decreased fluorescence intensity of tubulin and endoplasmic reticulum. Reduced tubulin signal may result from
lower proliferation rate of cells from control group. Interestingly, both ER and Golgi intensity was also reduced in that group, impinging on deceler-
ated metabolism rate. Magnification 9200, scale bars: 150 lm. Formation of MVs was visualized with TEM technique (B). A robust amount of MVs
(membrane-derived macrovesicles) was observed in 5-AZA group (B). Magnification 930.000, scale bars: 1 lm.
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oxide levels were progressively increasing during culture, although it
was significantly decreased in experimental group after both 48
(P < 0.05) and 168 (P < 0.01) hrs in comparison to control
(Fig. 6C). The activity of SOD decreased during time in the control
culture, while on the contrary, in 5-AZA cultures increased during the
culture period. Activity of SOD was higher in experimental group, but
only on seventh day, it was statistically important (P < 0.001)
(Fig. 6D). Moreover, the mRNA level of Lin28, was increased in ASCs
after 5-AZA treatment (Fig. 6E) (P < 0.05) in comparison to control
group. Interestingly, ATP production was also increased in that group
(Fig. 6F).
Detection of BAX, p21, p53 and Bcl-2 mRNA
Analysis of mitochondrial apoptosis related genes: BAX, p21 and also
tumour suppressor p53 gene expression was analysed in ASCs form
experimental and control cultures after 168 hrs of propagation. Quan-
titative analysis of transcripts revealed that expression of and p53
mRNA was significantly decreased in 5-AZA cultures (P < 0.001)
(Fig. 7A). Similarly, the level of p21 transcript was also decreased in
experimental cultures (P < 0.05) (Fig. 7B). The ratio of Bcl-2/BAX
mRNA was increased (P < 0.01) after 5-AZA treatment (Fig. 7C).
GAPDH was used as an endogenous control.
5-AZA treatment decreases DNA methylation
status and increases TET gene expression
Genomic distribution of 5-MC and 5-hMC was evaluated by
immunofluorescence staining after 168 hrs of culture to assess DNA
methylation status. Nuclei were counterstained with DAPI. The distri-
bution of investigated molecules was strongly affected by 5-AZA
(Fig. 8A). The 5-MC fraction was more robust in control group with
simultaneously decreased levels of 5-hMC. In ASCs treated with
5-AZA, 5-MC fraction was decreased, which resulted in increased
5-hMC positive fraction. We also determined relative gene expression
of TET2 and TET3, which are responsible for active regulation of DNA
methylation, after 168 hrs of propagation. GAPDH was used as an
endogenous control. Both, TET2 and TET3 mRNA levels (Fig. 8B, C)
were significantly increased after 5-AZA treatment, which strongly
correlates with the results of immunofluorescence methylation
Fig. 5 Evaluation of apoptosis and senescence in hASCs after 5-AZA treatment. Representative pictures showing live cells (stained green with Cal-
cein), dead cells (stained orange with Propidium Iodide) and merged (A). In addition, percentage of dead cells was calculated (B) showing less sus-
ceptibility for apoptosis in 5-AZA culture cells (P < 0.01). Staining for senescence-associated b-galactosidase (blue) (IV and IX). Differences in the
accumulation of b-galactosidase were determined based on the percentage of stained area (C) showing decreased expression of b-gal in cells cul-
tured with 5-AZA (P < 0.05). Moreover, immunofluorescence staining using anti-caspase-3 antibody, revealed higher expression of that protein in
control group (V, X). Nuclei were counterstained with DAPI. Magnifications: 9100, scale bars 250 lm. Abbreviations: dc- dead cell, b-gal-b-galacto-
sidase, cas-3- caspase 3. *P < 0.05, **P < 0.01.
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staining. Moreover, DNA methylation status was assessed quantita-
tively using ELISA test. We observed decreases in DNA methylation
after 5-AZA supplementation (Fig. 8D).
Discussion
Currently, regenerative medicine as well as tissue engineering is
searching for advance solutions, that can improve the regenerative
process of different tissues or organ damages. Because of the capac-
ity for self-renew and capabilities to differentiate into multiple lin-
eages, MSCs represent an important building block for cellular
therapies. Adult MSCs of various origins has been involved in wide
range of research, including ours, which proved their great therapeu-
tic potential. However, during ageing of organism, MSCs are losing
their ‘stemness’ character and thus, novel strategies that might reju-
venate their cytophysiological conditions in vitro, before clinical appli-
cation, are strongly required [36]. Here, we demonstrated that pre-
Fig. 6 Oxidative stress factors in hASCs are reduced after 5-AZA treatment. Images showing mitochondria stained with MitoRed dye (I, V) and accu-
mulation of intracellular reactive oxygen species (ROS, II, VI). Merged pictures revealed that most of ROS was derived from mitochondria. To inves-
tigate whether the amount of ROS correlates with mitochondria structure, we performed their imaging with TEM 930k, scale bars 1 lm. In control
group, we observed that some of mitochondria had disarrayed membranes and formed vacuoles within its matrix (indicated with arrows, IV). In 5-
AZA treated cells although mitochondria were smaller in shape, they presented typical morphology, e.g. typical, bean-shaped structure with intact
membranes and numerous cristae (VIII). Magnification: fluorescence stainings 9100, scale bars: 250 lm, TEM: 910k, scale bars: 2l. Amount of
ROS was also evaluated quantitatively with H2DCFDA after 48 and 168 hrs of culture (B). Moreover, we evaluated levels of nitric oxide and SOD.
Both assays confirmed positive influence of 5-AZA treatment on oxidative status of hASCs as it decreased nitric oxide production (C) simultaneously
with increased antioxidative protection coming from SOD (D). Moreover, using RT-PCR, we evaluated mean expression of Lin28 (E) which regulate
the self-renewal of stem cells and effects of its activation faded with age. After treatment with 5-AZA, we observed increased expression of Lin28
transcript (P < 0.05) in hASCs. Moreover, we observed increased ATP production in 5-AZA group (F). *P < 0.05, **P < 0.01, ***P < 0.001.
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treatment of MSCs, isolated from elderly donors, using 5-AZA might
be a successful way to reverse their aged phenotype and increase
therapeutic potential.
Ageing of stem cells is complex and yet, not fully understood pro-
cess. The lifelong persistence of MSCs within the body, makes them
susceptible for the accumulation of cellular damage which in turn
leads to senescence, apoptosis and decreased regenerative potential
[37]. Those impairments cause blunted responsiveness for tissue
injury, declining functional capacities and reduced effectiveness of
cells replacement in aged organisms [37]. Thus, it is crucial to under-
stand the molecular pathways involved with age-related impairment
of MSCs. Here, we have explored common ageing phenotypes of
Fig. 7 Reverse transcriptase–polymerase chain reaction (RT-PCR) results. After 168 hrs of culture, total RNA was isolated from the cells and RT-
PCR analysis were performed. The expression of both p53 (A) and p21 (B) apoptosis-related genes was significantly decreased in 5-AZA cultures
(P < 0.001). We also observed increased ratio of BCL-2/BAX in 5-AZA culture (C) (P < 0.01). *P < 0.05, **P < 0.01, ***P < 0.001.
Fig. 8 Distribution of 5-methylocytosine (5-MC), 5-hydroxymethylocytosine (5-hMC) and the TET mRNA levels. Genomic distribution of 5-MC (I, IV)
and 5-hMC (II, V) was evaluated using immunofluorescence stainings to determine DNA methylation status. Nuclei were counterstained with DAPI.
The 5- MC fraction was reduced after 5-AZA treatment, while 5-hMC fluorescence intensity was increased in this group in comparison to control.
Using TEM imaging cells nuclei were visualized (III, VII). Higher magnification images of boxed regions shown on the right depict heterochromatin
underneath the nuclear envelope. Interestingly, cells treated with 5-AZA displayed broad heterochromatin architecture at the nuclear periphery. Both
TET mRNA levels (B,C) were significantly increased (P < 0.001) after 5- AZA supplementation. Treating cells with 5-AZA not only reduced DNA
demethylation passively but also actively by inducing TET expression following increased 5-hMC fractions. DNA methylation assessment using ELISA
kit (D). Magnification 9100, scale bars 250 lm ***P < 0.001.
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hASCs including accumulation of ROS, antioxidative SOD protection,
mitochondria dysfunction, epigenetic status and the influence of 5-
AZA treatment on their occurrence.
As previously showed, hASCs isolated from aged donors,
although exhibit typical for MSCs morphology and phenotype (CD44+,
CD73+, CD90+ and CD34 CD45) comparing to young patients, have
suffered from lower expression of CD73 surface marker [15]. Thus,
bearing in mind that fact, in the current research, we investigated
hASCs of aged donors that exhibited impairment of CD73 surface
marker expression, for testing hypothesis if in vitro pre-treatment
using 5-AZA might improve their viability and cellular activity.
Interestingly, obtained data indicates that 5-AZA supplementation
affects the effectiveness of ASC differentiation potential. In performed
multipotency assay, we observed increased formation of extracellular
matrix and proteoglycans during osteo- and chondrogenesis respec-
tively. On the other hand, formation of lipid droplets during adipogen-
esis in 5-AZA treated cells seems to be reduced. The effects of 5-AZA
on ASC differentiation needs further study to be elucidated in more
details.
Since proliferation rate and viability of hASCs are considered as a
one of the most important factors, that directly corresponds with
regenerative process [38], we analysed proliferative activity (PA),
PDT, viability, and potential for creating colonies originated from sin-
gle cell (CFU-fs) under the effect of 5-AZA. We have found that hASCs
isolated from aged patients, that were supplemented with 5-AZA in
comparison to not-treated cells, however, still elderly patients cells,
exhibited significantly elevated PA, shortens PDT and typical for
MSCs spindle shape morphology. On the contrary, in control group
we observed cells with spread-out, flattened morphology and
increased nuclei size, typical features associated with ASC senes-
cence. What is more, we observed, that 5-AZA improves CFU-fs when
compared to not stimulated cells. Obtained data stands in good
agreement with Marinovic-Kulisic et al., findings, that also observed
pro-proliferative effect of 5-AZA in in vitro culture ofrat foetal epiglot-
tis [39]. Moreover, in the current research, we have found the highest
percentage of Ki67+ as well as BrdU positive cells in hASCs treated
with 5-AZA comparing to not-treated cells.
What is more, studies showed that not only the method of
administration, but also timing of delivery and number of cells
delivered are crucial in effectiveness of stem cells therapy [7].
Treatment of cells with 5-AZA enabled for extensive in vitro cell
expansion, in short period of time, which seems to be crucial when
taking into consideration above mentioned facts, costs of prolonged
culture and replicative senescence. In addition, scanning and trans-
mission electron microscope investigations revealed increased for-
mation of membrane derived vesicles (MV’s) in 5-AZA treated cells.
As it was shown by Ratajczak et al., [40] MVs play pivotal role in
stem cell therapies because of their paracrine effects. It was proved
that MVs riched in growth factors, cytokines, and RNA or microRNA
migrate to injury site and initiate healing process of damaged
organs. These observations from the regenerative process point of
view seems to be fundamental, since elevated cellular activity
together with increased paracrine activity of the cells treated with 5-
AZA may directly affects the course of tissue healing process
in vivo.
That elevated cellular activity and viability of aged hASCs treated
with 5-AZA may be partially explain by the up-regulation of Lin28
mRNA. It was previously showed, that Lin28 RNA binding protein,
that expression is up-regulated during embryogenesis, plays an fun-
damental role in development process, maintenance of pluripotency/
multipotency as well as regulation of the cellular metabolism [41].
Metabolism is now known to play pivotal role in dictating whether cell
proliferate or not. Likewise, it was clearly demonstrated, that Lin28
transcript promotes regeneration capacity in adult tissues by enhanc-
ing oxidative metabolism (glycolysis and oxidative phosphorylation)
and promoting bioenergetic state characteristic of embryonic cells. It
was shown that MSCs rely on glycolysis to remain quiescent state.
Thus, switching MSCs metabolism towards oxidative phosphorylation
may enhance differentiation process but on the other hand makes
cells more susceptible for ROS damage [42, 43].
In turn, oxidative metabolism which might be negatively unsettled
by the action of ROS and/or nitric oxide and impair MSCs cellular
function [44]. Increased amount of DNA methylation as well as accu-
mulation of ROS during ageing is a well-known phenomenon,
observed in aged cells. As it was shown by Brandl et al. [45], aged
MSCs are susceptible for oxidative stress damage, DNA strand breaks
followed by increased p53 and p21 expression. Hence, application of
5-AZA in in vitro culture of aged hASCs, that suffer from weaker activ-
ity of free radicals scavengers, like superoxide dismutase, might be
an effective tool that abolishes the consequences of oxidative stress
in aged hASCs. Here, we observed the lowest percentage of: (i) dead
cells, (ii) senescence cells [b-galactosidase positive cells] and (iii)
caspase-3 positive cells in this culture, where 5-AZA was incorpo-
rated. Moreover, we have found, that aged hASCs accumulated robust
amount of ROS within the mitochondria, simultaneously affecting
their ultrastructure and function, what partially might explained
impairment of proliferative activity of control, aged cells.
Previous findings of Stolzig et al. and others [46] clearly showed
link between accumulation of oxidative stress factors and mitochon-
dria impairment, especially in aged MSCs. Here, we confirmed this
regularity, showing that 5-AZA pre-treatment of aged hASCs resulted
in both: reduction in ROS and nitric oxide level with simultaneous
increase in SOD activity in elderly donors derived hASCs. Further-
more, in accordance with Stolzig and others, elevated oxidative stress
factors accumulation in aged donors stromal stem cells leads to acti-
vation of apoptotic action and finally through reducing their viability
and mitochondria dysfunctions induce apoptosis. Our findings
showed that those problems can be overcome by 5-AZA treatment, as
we observed increased activity of SOD, and decreased mRNA levels
of pro-apoptotic genes, i.e. p-21 and p-53. Simultaneously, we have
found, the up-regulation of BCL-2/BAX ratio. Thus, taking into consid-
eration above mentioned advantage of anti-apoptotic genes expres-
sion over pro-apoptotic, it might explain rejuvenated character of
hASCs of elderly donors when compared with not-treated cells.
In recent years, Lin28 emerged as a factor that define stemness in
several tissue lineage, play important role in metabolism, somatic
reprogramming and cancer. As it was also reported that Lin28 bound
to and enhanced the translation of mRNAs for several metabolic
enzymes, thereby oxidative phosphorylation, we decided to evaluate
its expression under control and 5-AZA conditions. We observed up-
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regulation of Lin28 mRNA in 5-AZA treated ASC. Increases of oxida-
tive glucose metabolism were also confirmed by ATP assay as we
observed increased production of ATP in 5-AZA group. Thus, it is
tempting to speculate that 5-AZA anti-ageing properties may results
from increased Lin28 expression, which in turn activates mRNA
translation and assembly of subunits of the mitochondrial complex
and switches in glucose metabolism.
Because of the great therapeutic potential of hASCs, wide range of
studies has been performed to investigate stem cell metabolism,
including functional modification of gene expression and epigenetic
modulations. Still, the data regarding the effects of epigenetic regula-
tors remain controversial. Study conducted by Rui et al. revealed that
epigenetic alternations of MSCs could be an attractive way to control
their differentiation [47]. Similarly, Qian et al. showed that 5-AZA
increased MSCs cardiomyogenesis [48].
Moreover, studies conducted by Yan et al., revealed that 5-AZA,
which inhibits the activity of DNA methyltransferases (DNMTs), pro-
moting DNA demethylation in aged hASCs simultaneously improves
their osteogenic differentiation potential. 5-AZA has been demon-
strated to be easily incorporated into DNA, methylate specific genes
and finally induces TET family genes expressions that convert nuclear
5-methylcyt-osine (5 mC) to 5 hmC [49]. Here, we have observed,
that 5-AZA pre-treatment in aged donors of hASCs abundantly trans-
ferred 5-methylcyt-osine (5 mC) to 5 hmC. In addition, immunofluo-
rescence data were confirmed quantitatively, as we observed
decreased DNA methylation status after 5-AZA supplementation.
Moreover, we noticed the higher expression of TET2/TET3 transcripts
on mRNA level that taking part in the process of 5mC to 5hmC trans-
formation. Targeting DNA methylation for epigenetic therapy involves
application of hypomethylation agents in the clinic to restore the
proper methylation status of cells. Our results indicates and con-
firmed demethylative character of 5-AZA in elderly donors hASCs,
and thus might become an essential factor in the process of hASCs
rejuvenation.
Taken together, MSCs contribute to peripheral tissue repair
in vivo and form a cell source for regenerative medicine. Their regen-
erative potential is impaired by cellular senescence and highly
depends on donor age. Accumulation of oxidative stress and
increased methylation status of DNA are well described phe-
nomenons, which lead to MSCs senescence. Our results indicates
that, treating hASCs with 5-AZA can be justified therapeutic interven-
tion, that can slow-down and even reverse aged- related degenerative
changes in those cells.
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